跳至主要内容
临床试验/NCT01174407
NCT01174407Unknown不适用

Is CD35, CD21 and CD55 Associated With Exudative Age-related Macular Degeneration

Rudolf Foundation Clinic1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2008年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration

研究概览

简要总结

The purpose of this study is to determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration. The aim is to asses a difference in expression rates of these factors on AMD-patients and a healthy control group.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Man and women over 18 years old
  • Filled out informed consent
  • Diagnosis of non-exudative/ exudative age related macular degeneneration

排除标准

  • Inherited retinal diseases
  • Other acquired retinal/ macular
  • Missing informed consent

结局指标

主要结局

determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration

时间窗: 1 day

次要结局

  • expression rates of on AMD-patients and a healthy control group(1 year)

研究者

发起方
Rudolf Foundation Clinic
申办方类型
Other

研究点 (1)

Loading locations...

相似试验